Abnormal Hippocampal Development in Children with Medulloblastoma Treated with Risk-Adapted Irradiation
Bonnie J. Nagela,g,
Shawna L. Palmera,
Wilburn E. Reddickb,f,
John O. Glassb,
Kathleen J. Heltonb,
Shengjie Wuc,
Xiaoping Xiongc,
Larry E. Kunb,
Amar Gajjard,e and
Raymond K. Mulherna,e
a Division of Behavioral Medicine, St Jude Childrens Research Hospital, Memphis
b Departments of Radiological Sciences, St Jude Childrens Research Hospital, Memphis
c Departments of Biostatistics and Epidemiology, St Jude Childrens Research Hospital, Memphis
d Departments of Hematology/Oncology, St Jude Childrens Research Hospital, Memphis
e Department of Pediatrics, University of Tennessee College of Medicine, Memphis
f Department of Electrical, Computer, and Biomedical Engineering, University of Memphis, TN
g Department of Psychiatry, University of California San Diego School of Medicine

View larger version (21K):
[in a new window]
|
FIG 1. Individual patients and predicted left hippocampal volumes over time since diagnosis (DX).
| |

View larger version (21K):
[in a new window]
|
FIG 2. Individual patients and predicted right hippocampal volumes over time since diagnosis (DX).
| |

View larger version (127K):
[in a new window]
|
FIG 3. T1-weighted MR image represents the midsagittal orientation of a dosimetry map for a high-risk patient. Small dose-map area (white outlined posterior fossa area) receives the highest total CSI dose (up to 60Gy).
| |